162 related articles for article (PubMed ID: 38519745)
41. A new AI-assisted scoring system for PD-L1 expression in NSCLC.
Huang Z; Chen L; Lv L; Fu CC; Jin Y; Zheng Q; Wang B; Ye Q; Fang Q; Li Y
Comput Methods Programs Biomed; 2022 Jun; 221():106829. PubMed ID: 35660765
[TBL] [Abstract][Full Text] [Related]
42. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
Ehteshami Bejnordi B; Veta M; Johannes van Diest P; van Ginneken B; Karssemeijer N; Litjens G; van der Laak JAWM; ; Hermsen M; Manson QF; Balkenhol M; Geessink O; Stathonikos N; van Dijk MC; Bult P; Beca F; Beck AH; Wang D; Khosla A; Gargeya R; Irshad H; Zhong A; Dou Q; Li Q; Chen H; Lin HJ; Heng PA; Haß C; Bruni E; Wong Q; Halici U; Öner MÜ; Cetin-Atalay R; Berseth M; Khvatkov V; Vylegzhanin A; Kraus O; Shaban M; Rajpoot N; Awan R; Sirinukunwattana K; Qaiser T; Tsang YW; Tellez D; Annuscheit J; Hufnagl P; Valkonen M; Kartasalo K; Latonen L; Ruusuvuori P; Liimatainen K; Albarqouni S; Mungal B; George A; Demirci S; Navab N; Watanabe S; Seno S; Takenaka Y; Matsuda H; Ahmady Phoulady H; Kovalev V; Kalinovsky A; Liauchuk V; Bueno G; Fernandez-Carrobles MM; Serrano I; Deniz O; Racoceanu D; Venâncio R
JAMA; 2017 Dec; 318(22):2199-2210. PubMed ID: 29234806
[TBL] [Abstract][Full Text] [Related]
44. Artificial intelligence scale-invariant feature transform algorithm-based system to improve the calculation accuracy of Ki-67 index in invasive breast cancer: a multicenter retrospective study.
Xie N; Zhou H; Yu L; Huang S; Tian C; Li K; Jiang Y; Hu ZY; Ouyang Q
Ann Transl Med; 2022 Oct; 10(19):1067. PubMed ID: 36330383
[TBL] [Abstract][Full Text] [Related]
45. A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma.
Sakamoto T; Furukawa T; Pham HHN; Kuroda K; Tabata K; Kashima Y; Okoshi EN; Morimoto S; Bychkov A; Fukuoka J
Histopathology; 2022 Dec; 81(6):758-769. PubMed ID: 35989443
[TBL] [Abstract][Full Text] [Related]
46. "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring.
Engelberg JA; Retallack H; Balassanian R; Dowsett M; Zabaglo L; Ram AA; Apple SK; Bishop JW; Borowsky AD; Carpenter PM; Chen YY; Datnow B; Elson S; Hasteh F; Lin F; Moatamed NA; Zhang Y; Cardiff RD
Hum Pathol; 2015 Nov; 46(11):1694-704. PubMed ID: 26410019
[TBL] [Abstract][Full Text] [Related]
47. Development and Validation of an Artificial Intelligence-Powered Platform for Prostate Cancer Grading and Quantification.
Huang W; Randhawa R; Jain P; Iczkowski KA; Hu R; Hubbard S; Eickhoff J; Basu H; Roy R
JAMA Netw Open; 2021 Nov; 4(11):e2132554. PubMed ID: 34730818
[TBL] [Abstract][Full Text] [Related]
48. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
[TBL] [Abstract][Full Text] [Related]
49. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
[TBL] [Abstract][Full Text] [Related]
50. Improving Ki67 assessment concordance by the use of an artificial intelligence-empowered microscope: a multi-institutional ring study.
Cai L; Yan K; Bu H; Yue M; Dong P; Wang X; Li L; Tian K; Shen H; Zhang J; Shang J; Niu S; Han D; Ren C; Huang J; Han X; Yao J; Liu Y
Histopathology; 2021 Oct; 79(4):544-555. PubMed ID: 33840132
[TBL] [Abstract][Full Text] [Related]
51. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.
Tafjord S; Bøhler PJ; Risberg B; Torlakovic E
Diagn Cytopathol; 2002 Mar; 26(3):137-41. PubMed ID: 11892015
[TBL] [Abstract][Full Text] [Related]
52. Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response.
Choi S; Cho SI; Ma M; Park S; Pereira S; Aum BJ; Shin S; Paeng K; Yoo D; Jung W; Ock CY; Lee SH; Choi YL; Chung JH; Mok TS; Kim H; Kim S
Eur J Cancer; 2022 Jul; 170():17-26. PubMed ID: 35576849
[TBL] [Abstract][Full Text] [Related]
53. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.
Akbar S; Jordan LB; Purdie CA; Thompson AM; McKenna SJ
Br J Cancer; 2015 Sep; 113(7):1075-80. PubMed ID: 26348443
[TBL] [Abstract][Full Text] [Related]
54. Deep Learning-Based Computational Cytopathologic Diagnosis of Metastatic Breast Carcinoma in Pleural Fluid.
Park HS; Chong Y; Lee Y; Yim K; Seo KJ; Hwang G; Kim D; Gong G; Cho NH; Yoo CW; Choi HJ
Cells; 2023 Jul; 12(14):. PubMed ID: 37508511
[TBL] [Abstract][Full Text] [Related]
55. Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.
Welsh AW; Moeder CB; Kumar S; Gershkovich P; Alarid ET; Harigopal M; Haffty BG; Rimm DL
J Clin Oncol; 2011 Aug; 29(22):2978-84. PubMed ID: 21709197
[TBL] [Abstract][Full Text] [Related]
56. Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer.
Kim H; Kim S; Choi S; Park C; Park S; Pereira S; Ma M; Yoo D; Paeng K; Jung W; Park S; Ock CY; Lee SH; Choi YL; Chung JH
JCO Precis Oncol; 2024 May; 8():e2300556. PubMed ID: 38723233
[TBL] [Abstract][Full Text] [Related]
57. Impact of artificial intelligence on pathologists' decisions: an experiment.
Meyer J; Khademi A; Têtu B; Han W; Nippak P; Remisch D
J Am Med Inform Assoc; 2022 Sep; 29(10):1688-1695. PubMed ID: 35751441
[TBL] [Abstract][Full Text] [Related]
58. Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens.
Hendry S; Byrne DJ; Christie M; Steinfort DP; Irving LB; Wagner CA; Ellwood T; Cooper WA; Fox SB
Cytopathology; 2020 Mar; 31(2):90-95. PubMed ID: 31808243
[TBL] [Abstract][Full Text] [Related]
59. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
Asogan AB; Hong GS; Arni Prabhakaran SK
Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
Makhlouf S; Wahab N; Toss M; Ibrahim A; Lashen AG; Atallah NM; Ghannam S; Jahanifar M; Lu W; Graham S; Mongan NP; Bilal M; Bhalerao A; Snead D; Minhas F; Raza SEA; Rajpoot N; Rakha E
Br J Cancer; 2023 Nov; 129(11):1747-1758. PubMed ID: 37777578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
